首页> 外文期刊>Retina >Vitrectomy and panretinal photocoagulation reduces the occurrence of neovascular glaucoma in central retinal vein occlusion with vitreous hemorrhage
【24h】

Vitrectomy and panretinal photocoagulation reduces the occurrence of neovascular glaucoma in central retinal vein occlusion with vitreous hemorrhage

机译:玻璃体切除术和全视网膜光凝可减少视网膜中央静脉阻塞伴玻璃体出血的新生血管性青光眼的发生

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: The purpose of this study was to evaluate the best-corrected visual acuity and occurrence of neovascular glaucoma with vitrectomy (VT) and panretinal photocoagulation or without VT in central retinal vein occlusion (CRVO) associated with vitreous hemorrhage (VH).METHODS: The charts from patients diagnosed as having CRVO with VH at Chang Gung Memorial Hospital (Taiwan) were reviewed.They were grouped based on whether they also underwent VT.The main outcome measurements were the best-corrected visual acuity and incidence of neovascular glaucoma.RESULTS: There were 83 eyes that had CRVO with VH from 83 patients (VT group, 56 eyes; non-VT group, 27 eyes).There was no significant difference between the VT and non-VT groups in terms of age, gender, diabetes, hypertension, lens status, and follow-up period.The non-VT group had a better best-corrected visual acuity (P = 0.018) and less VH (P = 0.025) than the VT group at baseline; however, the VT group had a better best-corrected visual acuity at the end of the follow-up than the non-VT group (P < 0.001).Most importantly, there was a higher neovascular glaucoma development (37%) in the non-VT group compared with that (14.3%) in the VT group (P = 0.025).CONCLUSION: The visual outcomes of CRVO with VH are unfavorable whether VT was performed.However, VT and panretinal photocoagulation improved visual acuity and reduced the incidence of neovascular glaucoma in CRVO with VH.
机译:目的:本研究的目的是评估玻璃体切除术(VT)和全视网膜光凝或无VT的视网膜中央视网膜静脉阻塞(CRVO)与玻璃体出血(VH)相关的最佳矫正视力和新生血管性青光眼的发生率。回顾了台湾长庚纪念医院确诊为VH的CRVO患者的图表,根据是否也进行了VT进行分组,主要结局指标是最佳矫正视力和新生血管性青光眼的发生率。 :83例患者中83例患有VH的CRVO(VT组56眼;非VT组27眼)。在年龄,性别,糖尿病方面,VT和非VT组之间无显着差异在基线时,非VT组的最佳矫正视力(P = 0.018)和VH(P = 0.025)要好于非VT组;但是,VT组在随访结束时的视力得到最佳矫正,比非VT组更好(P <0.001)。最重要的是,非VT组新生血管性青光眼的发生率更高(37%)。 -VT组与VT组相比(14.3%)(P = 0.025)。结论:是否行VT的CRVO合并VH的视觉效果均不理想,但是VT和全视网膜光凝可提高视力并降低发生率。伴VH的CRVO中的新生血管性青光眼。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号